stockrowElanco Animal Health Incorporated (ELAN) vs Kiniksa Pharmaceuticals International, plc (KNSA)
- Elanco Animal Health Incorporated ELAN 23.74 −6.20%
- Kiniksa Pharmaceuticals International, plc KNSA 88.50 −7.93%
Elanco Animal Health Incorporated and Kiniksa Pharmaceuticals International, plc are both Drug Manufacturers Specialty & Generic companies. Elanco Animal Health Incorporated is the larger, with a market value of $11.8B against $6.9B — 1.7× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; Kiniksa Pharmaceuticals International, plc trades at 62.1×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.2% against 12.0%. Kiniksa Pharmaceuticals International, plc has the higher net margin (11.6% vs −3.96%) and the higher return on invested capital (57.7% vs 0.51%). Across the 19 metrics below, Kiniksa Pharmaceuticals International, plc leads on 13 and Elanco Animal Health Incorporated on 6.
Valuation
Profitability
| Metric | ELAN | KNSA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.36% | 90.16% | 53.51% |
| Operating margin | 1.61% | 13.79% | 0.00% |
| Net margin | (3.96%) | 11.58% | (2.45%) |
| Free cash flow margin | 7.55% | 20.85% | 0.00% |
| Return on equity | (2.98%) | 17.59% | (0.80%) |
| Return on assets | (1.46%) | 12.92% | (1.67%) |
| Return on invested capital | 0.51% | 57.65% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack